Evidence map›Paper›PMID 26633173›Full record

ArticlePloS one2015

A Chemical and Enzymatic Approach to Study Site-Specific Sumoylation.

Claudio P Albuquerque, Eyan Yeung, Shawn Ma, Ting Fu, Kevin D Corbett, Huilin Zhou

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Claudio P AlbuquerqueLudwig Institute for Cancer Research, University of California San Diego, La Jolla, California, United States of America.
Eyan YeungLudwig Institute for Cancer Research, University of California San Diego, La Jolla, California, United States of America.
Shawn MaLudwig Institute for Cancer Research, University of California San Diego, La Jolla, California, United States of America.
Ting FuLudwig Institute for Cancer Research, University of California San Diego, La Jolla, California, United States of America.
Kevin D CorbettLudwig Institute for Cancer Research, University of California San Diego, La Jolla, California, United States of America.
Huilin ZhouLudwig Institute for Cancer Research, University of California San Diego, La Jolla, California, United States of America.

Funding

Molecular mechanisms of chromosome organization and recombination control by the meiotic chromosome axis.R01GM104141 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CORBETT, KEVIN DANIEL · 2013 to 2021
$3.1M
Suppression of duplication-mediated genome rearrangements by protein sumoylationR01GM116897 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZHOU, HUILIN · 2015 to 2023
$2.6M
NIGMS NIH HHS GM104141NIGMS NIH HHS GM116897NIGMS NIH HHS R01 GM104141NIGMS NIH HHS R01 GM116897
6 · The paper itself

Abstract

A variety of cellular pathways are regulated by protein modifications with ubiquitin-family proteins. SUMO, the Small Ubiquitin-like MOdifier, is covalently attached to lysine on target proteins via a cascade reaction catalyzed by E1, E2, and E3 enzymes. A major barrier to understanding the diverse regulatory roles of SUMO has been a lack of suitable methods to identify protein sumoylation sites. Here we developed a mass-spectrometry (MS) based approach combining chemical and enzymatic modifications to identify sumoylation sites. We applied this method to analyze the auto-sumoylation of the E1 enzyme in vitro and compared it to the GG-remnant method using Smt3-I96R as a substrate. We further examined the effect of smt3-I96R mutation in vivo and performed a proteome-wide analysis of protein sumoylation sites in Saccharomyces cerevisiae. To validate these findings, we confirmed several sumoylation sites of Aos1 and Uba2 in vivo. Together, these results demonstrate that our chemical and enzymatic method for identifying protein sumoylation sites provides a useful tool and that a combination of methods allows a detailed analysis of protein sumoylation sites.

Indexed as

Mass SpectrometryProtein Processing, Post-TranslationalSaccharomyces cerevisiaeSmall Ubiquitin-Related Modifier ProteinsSumoylationUbiquitinSmall Ubiquitin-Related Modifier ProteinsUbiquitin

Identifiers

PMID26633173
PMCPMC4669148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.